Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

In this interview, News Medical speaks with Guillaume Bentzinger, Project Manager at Novalix; Luis Carrillo, Managing Director at De Dietrich France; Philippe Robin CEO of Alysophil; and Alejandro ...

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...

As organisations accelerate digital onboarding and automated compliance processes, the security and reliability of verification APIs are coming under increased scrutiny. For development teams, the ...

Cequence Security, the provider of unified API protection, is unveiling the latest testing capabilities—API Security Testing—for its unified API protection platform. Focused on pre-production ...

Acquisition adds API security testing to Radware’s comprehensive API security portfolio, extending protection to all stages of the API lifecycleMAHWAH, N.J., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Radware® ...